Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended: December 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ___________ to____________

Commission File Number: 333-257458

CYTTA CORP.

(Exact name of registrant as specified in its charter)

Nevada

98-0505761

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

5450 W Sahara Ave Suite 300A

Las Vegas NV 89146

(Address of principal executive offices) (zip code)

(702) 900-7022

(Registrant’s telephone number, including area code)

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of February 14, 2024, there were 441,946,581 shares outstanding of the registrant’s common stock, $0.001 par value per share.

CYTTA CORP.

INDEX

PART I. FINANCIAL INFORMATION

ITEM 1	Financial Statements (Unaudited)	3
	Condensed Balance Sheets as of December 31, 2023, and September 30, 2023 (Unaudited)	3
	Condensed Statement of Operations for the three months ended December 31, 2023, and 2022 (Unaudited)	4
	Condensed Statement of Changes in Stockholders’ Deficit for the three months ended December 31, 2023, and 2022 (Unaudited)	5
	Condensed Statement of Cash Flows for the three months ended December 31, 2023, and 2022 (Unaudited)	6
	Notes to Interim Unaudited Condensed Financial Statements	7
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	27
ITEM 4.	Controls and Procedures	27

PART II. OTHER INFORMATION

ITEM 1.	Legal Proceedings	28
ITEM 1A.	Risk Factors	28
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28
ITEM 3.	Defaults Upon Senior Securities	28
ITEM 4.	Mine Safety Disclosures	28
ITEM 5.	Other Information	28
ITEM 6.	Exhibits	29

Table of Contents

CYTTA CORP.
BALANCE SHEETS
(Unaudited)

	December 31,			September 30,
	2023			2023
ASSETS
Current Assets
Cash	$	390,262		$	674,824
Prepaid expenses		639,764			986,976
Total Current Assets		1,030,026			1,661,800

Prepaid expenses, non-current		456,443			561,776
Property and equipment, net		66,982			77,558
TOTAL ASSETS	$	1,553,451		$	2,301,134

LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued expenses	$	553,942		$	546,335
Related party liabilities		803,447			772,532
Dividend payable		33,427			33,427
Deferred revenue		-			2,411
Note payable		40,000			40,000
Convertible notes payable, net of discount		1,222,141			1,166,788
Total Current Liabilities		2,652,957			2,561,493

COMMITMENTS AND CONTINGENCIES		-			-

Stockholders' Equity (Deficit)
Preferred stock par value $0.001; (100,000,000 shares authorized)
Series C Preferred Stock par value $0.001; (12,000,000 shares authorized and 600,000 issued and outstanding)		600			600
Series D Preferred Stock par value $0.001; (10,000,000 shares authorized and 50,000 shares issued and outstanding		50			50
Series E Preferred Stock par value $0.001; (13,650,000 shares authorized and -0- issued and outstanding		-			-
Series F Preferred Stock par value $0.001; (10,000,000 shares authorized and -0- issued and outstanding		-			-
Common stock par value $0.001; (500,000,000 shares authorized and 434,718,920 (December 31, 2023) and 426,831,170 (September 30, 2023) shares issued and outstanding)		434,720			426,832
Additional paid in capital		32,127,732			31,915,639
Accumulated Deficit		(33,662,608	)		(32,603,480	)
Total Stockholders' Equity (Deficit)		(1,099,506	)		(260,359	)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	1,553,451		$	2,301,134

The accompanying notes are an integral part of these statements

Table of Contents

CYTTA CORP.
STATEMENT OF OPERATIONS
(Unaudited)

	For the Three Months Ended December 31,
	2023			2022

Revenues	$	2,411		$	5,706

Operating Expenses:
General and administration- related party expenses		213,208			177,868
General and administrative- other		777,244			928,575
Total operating expenses		990,452			1,106,443

Loss from Operations		(988,041	)		(1,100,737	)

Other expenses (income)
Interest expense		71,287			26
Interest income		(200	)		(55	)
Total Other Expenses (Income)		71,087			(29	)

Loss before income taxes		(1,059,128	)		(1,100,708	)
Provision for income taxes		-			-
Net loss	$	(1,059,128	)	$	(1,100,708	)

Loss per share, basic and diluted	$	(0.00	)	$	(0.00	)

Weighted average shares outstanding Basic and diluted		428,575,956			380,882,100

The accompanying notes are an integral part of these statements

Table of Contents

CYTTA CORP.

Statement of Changes in Stockholders' Equity (Deficit)

The Three Months Ended December 31, 2023

(Unaudited)

	Series C Preferred Stock				Series D Preferred Stock				Series E Preferred Stock				Series F Preferred Stock				Common Stock				Additional Paid-in		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Equity (Deficit)
Balance September 30, 2023		600,000	$	600		50,000	$	50		-	$	-		-	$	-		426,831,170	$	426,832	$	31,915,639	$	(32,603,480	)	$	(260,359	)

Common stock and warrants issued for services		-		-		-		-		-		-		-		-		6,000,000		6,000		163,200		-			169,200

Common stock issued for accounts payable and accrued liabilities		-		-		-		-		-		-		-		-		1,887,750		1,888		48,893		-			50,781

Net loss for the three months ended December 31, 2023		-		-		-		-		-		-		-		-		-		-		-		(1,059,128	)		(1,059,128	)
Balance December 31, 2023		600,000	$	600		50,000	$	50		-	$	-		-	$	-		434,718,920	$	434,720	$	32,127,732	$	(33,662,608	)	$	(1,099,506	)

CYTTA CORP.

Statement of Changes in Stockholders' Equity

The Three Months Ended December 31, 2022

(Unaudited)

	Series C Preferred Stock				Series D Preferred Stock				Series E Preferred Stock				Series F Preferred Stock				Common Stock				Additional Paid-in		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Equity
Balance September 30, 2022		600,000	$	600		50,000	$	50		-	$	-		-	$	-		379,760,670	$	379,761	$	27,956,388	$	(27,875,007	)	$	461,792

Common stock issued for services		-		-		-		-		-		-		-		-		3,925,000		3,925		403,350		-			407,275

Net loss for the three months ended December 31, 2022		-		-		-		-		-		-		-		-		-		-		-		(1,100,708	)		(1,100,708	)
Balance December 31, 2022		600,000	$	600		50,000	$	50		0	$	-		0	$	-		383,685,670	$	383,686	$	28,359,738	$	(28,975,715	)	$	(231,641	)

The accompanying notes are an integral part of these statements

Table of Contents

CYTTA CORP.

Statements of Cash Flows

(Unaudited)

	For the Three Months Ended December 31,
	2023			2022

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss	$	(1,059,128	)	$	(1,100,708	)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expenses for services		599,516			407,275
Amortization of note discounts		15,353			-
Loss on debt extinguishment		3,955			-
Depreciation expense		10,576			11,904
Changes in Operating Assets and Liabilities:
Accounts Receivable		-			(4,995	)
Prepaid expenses		63,285			5,969
Accounts payable and accrued liabilities		31,252			101,376
Accounts payable-related party		13,040			(59,365	)
Deferred revenue		(2,411	)		26,763
Net cash used in operating activities		(324,562	)		(611,781	)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issuance of short-term convertible notes payable		40,000			-
Net cash provided by financing activities		40,000			-

NET CHANGE IN CASH		(284,562	)		(611,781	)
CASH AT BEGINNING OF PERIOD		674,824			755,122
CASH AT END OF PERIOD	$	390,262		$	143,341

SUPPLEMENTAL CASH FLOW DISCLOSURES

Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	-		$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES

Common stock issued for services	$	169,200		$	407,275
Common stock issued for accounts payable and accrued liabilities	$	50,781		$	-

The accompanying notes are an integral part of these statements

Table of Contents

Cytta Corp.

Notes to Financial Statements

December 31, 2023

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

Cytta Corp., (“Cytta” or the “Company”) was incorporated on May 30, 2006, under the laws of the State of Nevada. It is located in Las Vegas, Nevada. Cytta is in the business of imagineering, developing and securing disruptive technologies.

NOTE 2 - GOING CONCERN

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of December 31, 2023, the Company had an accumulated deficit of $33,662,608 and has also generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern.

The Company's proprietary CyttaCOMMS incident management system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES, is a game-changer in ensuring the safety and well-being of individuals in educational institutions and beyond. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency, even in low bandwidth environments in conjunction with their compression Licensee Reticulate Micro, Inc.

We also offer a combination of technical and consulting services, proprietary software products, hardware products utilizing our software and system integration team to meet the needs of customers. Cytta places extreme value on satisfying our customers’ needs with innovative, well-engineered, high-quality products and service solutions.

Cytta’s proprietary SUPR Intelligence, Surveillance and Reconnaissance (ISR) technology designated CyttaCOMP, is now licensed to Reticulate Micro, Inc., CyttaCOMP, is at the core of our products and is the most potent software codec commercially available. CyttaCOMP is explicitly designed for realtime streaming of HD, 4K, and higher resolution video while requiring only limited bandwidth and minimal computational resources.

Cytta’s IGAN Incident Command System (ICS) system seamlessly streams and integrates all available video and audio sources during emergencies, enabling sharing of multiple video and audio inputs. The IGAN ICS introduces immediate real-time video and audio situational awareness, which is valuable for police, firefighters, first responders, emergency medical workers, industry, environmental and emergencies, security, military, and all their command centers in any emergency.The IGAN technology powers, Cytta’s SaaS Based COMMS system creates an integrated communications platform which seamlessly streams all available video and audio sources in all critical situations, for first responders enabling real time event and interactive mapping information. Also based upon the IGAN technology, Cytta’s CARES (Crisis Alert and Response Emergency System) system is an innovative SAAS solution designed to enhance safety and security in educational institutions especially during emergency situations. This comprehensive system provides real-time alerts, rapid two-way secure video communication, and efficient response coordination with live location tracking to emergency response teams.

We have created advanced video compression, video/audio collaboration software, and portable hardware systems that solve real world problems in large markets. We believe our products will enable and empower the world to consume higher quality video anywhere, anytime. Our ultimate goal is to deliver such high-quality video that it is not discernible from reality with the naked eye creating ‘Reality Delivered’ for the Metaverse.

The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.

Table of Contents

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of December 31, 2023, and the results of operations and cash flows for the periods presented. The results of operations for the three months ended December 31, 2023, are not necessarily indicative of the operating results for the full fiscal year or any future period.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at December 31, 2023, and September 30, 2023.

Prepaid expenses

The Company considers expenses or services paid for prior to the period the expense is completed to be recorded as a prepaid expense. Included in this account is the value of common stock, options and warrants issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-two-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the three months ended December 31, 2023, and 2022 is summarized as:

	December 31,
	2023			2022
Balance beginning of period	$	1,548,752		$	32,897
Amortization of stock-based compensation		(389,260	)		-
Other prepaid expense activity		(63,285	)		(5,970	)
Sub-total		1,096,207			26,927
Less non-current portion		456,443			-
Prepaid expenses, current portion	$	639,764		$	26,927

Inventory

Inventories are valued at the lower of cost or net realizable value, with cost determined on the first-in, first-out basis. Inventory costs include finished goods and component parts. In evaluating the net realizable value of inventory, management also considers, if applicable, other factors, including known trends, market conditions, currency exchange rates and other such issues.

Property and equipment

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

Table of Contents

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

	Vehicles and equipment	5 years
	Software	3 years

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

In August 2020, the FASB issued Accounting Standards Update 2020-06 (ASU 2020-06). ASU 2020-06 eliminates the beneficial conversion feature and cash conversion models in Accounting Standards Codification 470-20 that require separate accounting for embedded conversion features in convertible instruments. The new guidance also eliminates some of the conditions that must be met for equity classification under ASC 815-40-25. The standard is effective for smaller reporting companies for annual periods beginning after December 15, 2023. Early adoption is permitted. The Company chose to early adopt this standard. As a result, financial results contained herein are reported in accordance with this standard as applicable.

The convertible debt issued by the company referred to in Note 7, did not require separate accounting for the conversion feature as it was not considered to be a derivative. The company issued warrants in connection with the debt financing and in accordance with ASC 470-20-25-2 the proceeds from the sale of the debt instruments have been allocated to the debt and warrants based on the relative fair value of the two components. The amount allocated to the warrants has been recorded as a debt discount to be amortized of the life of the note.

Fair value of financial instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

	●	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	●	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, other current assets, accounts payable and accrued expenses, certain notes payable and notes payable - related party, approximate their fair values because of the short maturity of these instruments.

Table of Contents

Revenue recognition

Effective January 1, 2018, the Company adopted ASC 606 — Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from the commercial sales of products by: (1) identify the contract (if any) with a customer; (2) identify the performance obligations in the contract (if any); (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract (if any); and (5) recognize revenue when each performance obligation is satisfied. The Company has no outstanding contracts with any of its’ customers. The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product and is based on the applicable shipping terms.

Stock-based compensation

The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.

Income taxes

The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes” (“SFAS No. 109”) (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

Cash flows reporting

The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

Reporting segments

ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment.

Table of Contents

Concentrations of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

Earnings (Loss) Per Share of Common Stock

The Company has adopted ASC 260-10-20, “Earnings per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

Recent Accounting Pronouncements

Other than the above there have been no recent accounting pronouncements or changes in accounting pronouncements during the quarter ended December 31, 2023, that are of significance or potential significance to the Company.

NOTE 4 - PROPERTY AND EQUIPMENT

The following table represents the Company’s property and equipment as of December 31, 2023, and September 30, 2023:

	December 31, 2023			September 30, 2023
Property and equipment	$	230,900		$	230,900
Accumulated depreciation		(163,918	)		(153,342	)
Property and equipment, net	$	66,982		$	77,558

Depreciation expense was $10,576 and $11,904 for the three months ended December 31, 2023, and 2022, respectively.

NOTE 5 - RELATED PARTY TRANSACTIONS

Related Party agreements and fees

For the three months ended December 31, 2023, and 2022, the Company recorded expenses to related parties in the following amounts:

	Three months ended December 31,
	2023		2022
Management fees, Chief Executive Officer (CEO)	$	45,000	$	60,000
Chief Technology Officer (CTO) through April 30, 2023		-		60,000
Chief Administration Officer (CAO) through January 31, 2023		-		45,000
President and Chief Operating Officer (COO)		45,000		-
Stock-based compensation expense, officers		123,208		-
Office rent and expenses		-		12,868
Total	$	213,208	$	177,868

On January 1, 2022, the Company increased the monthly fee from $15,000 to $18,000 for the CEO and CTO, respectively, and on February 1, 2022, the monthly fee for the CEO and CTO was increased to $20,000. Effective January 1, 2023, the monthly fee for the CEO and CTO was reduced to $15,000. Effective April 1, 2023, the Company was no longer compensating the CTO and did not incur any additional office rent and expenses.

Table of Contents

Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 shares per month, to be certificated semi-annually. Additionally, the Company granted an option to purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. For the three months ended December 31, 2023, the Company recorded an expense of $17,875 related to the 250,000 shares per month. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $53,295 is included in General and Administrative expenses-related party for the three months ended December 31, 2023. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $52,038 is included in General and Administrative expenses-related party for the three months ended December 31, 2023.

On October 25, 2020, the Company entered a sublease with its CTO, whereby the Company agreed to an annual lease payment of $50,000. On October 26, 2021, the Company renewed the lease for an additional year for $3,500 per month, and on October 26, 2022, the lease was renewed on a month-to-month basis. Included in office rent for the three months ended December 31, 2022, is $10,500.

Accounts payable, related parties

As of December 31, 2023, and September 30, 2023, the Company owes $803,447 and $772,532, respectively, to related parties as follows:

	December 31, 2023		September 30, 2023
Management fees, Chief Executive Officer (CEO)	$	123,040	$	110,000
Bonus, CEO		70,000		70,000
Stock to be issued President and COO		580,407		562,532
Fees, bonus, and accounts payable, former CTO		30,000		30,000
Total	$	803,447	$	772,532

NOTE 6 - NOTE PAYABLE

On January 10, 2023, the Company entered into an 8%, $40,000 face value unsecured promissory note with a third-party lender with a maturity date the earlier of the Company raising $1,000,000 in debt or equity, or January 10, 2024. Effective January 10, 2024, the lender amended and restated the note with a principal balance of $43,200, that matures on the six-month anniversary with an interest rate of 8%.

NOTE 7 - CONVERTIBLE NOTES PAYABLE

On February 10, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $50,000, to an investor. The note bears an interest rate of 18% per annum and matures on July 1, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock and the RM Stock resulted in a debt discount of $43,416, with the offset to additional paid in capital. For the three months ended December 31, 2023, amortization of the debt discounts of $7,662 was charged to interest expense. As of December 31, 2023, the outstanding principal balance of this note was $50,000 with a carrying value of $34,112, net of unamortized discounts of $15,888. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

Table of Contents

On February 17, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $25,000, to an investor. The note bears an interest rate of 18% per annum and matures on February 17, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On February 24, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $25,000, to an investor. The note bears an interest rate of 18% per annum and matures on February 24, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On February 28, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $10,000, to an investor. The note bears an interest rate of 18% per annum and matures on February 28, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On March 3, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $50,000, to an investor. The note bears an interest rate of 18% per annum and matures on July 1, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. In conjunction with this note, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock and the RM Stock resulted in a debt discount of $43,585, with the offset to additional paid in capital. For the three months ended December 31, 2023, amortization of the debt discounts of $7,692 was charged to interest expense. As of December 31, 2023, the outstanding principal balance of this note was $50,000 with a carrying value of $33,029, net of unamortized discounts of $16,971. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On May 3, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $50,000, to an investor. The note bears an interest rate of 18% per annum and matures on May 3, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.02, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

Table of Contents

On June 16, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $500,000, to an investor. The note bears an interest rate of 18% per annum and matures on June 16, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On August 2, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $500,000, to an investor. The note bears an interest rate of 18% per annum and matures on August 2, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On August 2, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $5,000, to an investor. The note bears an interest rate of 18% per annum and matures on August 2, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

On December 28, 2023, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $40,000, to an investor. The note bears an interest rate of 18% per annum and matures on December 28, 2024. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note.

The Company has the following convertible notes payable outstanding as of December 31, 2023, and September 30, 2023:

SCHEDULE OF NOTES PAYABLE

	December 31, 2023		September 30, 2023
Convertible note payable, interest at 18%, matures February 17, 2024	$	25,000	$	25,000
Convertible note payable, interest at 18%, matures February 24, 2024		25,000		25,000
Convertible note payable interest at 18%, matures February 28, 2024		10,000		10,000
Convertible note payable interest at 18%, matures May 3, 2024		50,000		50,000
Convertible note payable interest at 18%, matures June 16, 2024		500,000		500,000
Convertible note payable $50,000 face value, interest at 18%, matures July 1, 2024, net of discount of $15,888 (December) and $23,549 (September)		34,112		26,451
Convertible note payable $50,000 face value, interest at 18%, matures July 1, 2024, net of discount of $16,971 (December) and $24,663 (September)		33,029		25,337
Convertible note payable interest at 18%, matures August 2, 2024		500,000		500,000
Convertible note payable interest at 18%, matures August 2, 2024		5,000		5,000
Convertible note payable interest at 18%, matures December 28, 2024		40,000		-
Convertible notes payable, net of discounts of $32,859 (December) and $48,212 (September)	$	1,222,141	$	1,166,788

Table of Contents

NOTE 8 - CAPITAL STOCK

Common Stock

The Company has authorized 500,000,000 common shares, par value $0.001. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. As of December 31, 2023, and September 30, 2023, there were 434,718,920 and 426,831,170 common shares issued and outstanding respectively.

During the three months ended December 31, 2023, the following shares of common stock were issued:

	·	6,000,000 shares of common issued for services. The Company valued the shares at $169,200 based on the price of the common stock on the date the Company agreed to issue the shares.

	·	1,887,750 shares issued for payment of $46,826 of accounts payable and accrued interest. The value of the shares issued was $50,781 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $3,955 in loss on debt extinguishment for the three months ended December 31, 2023.

During the three months ended December 31, 2022, the following shares of common stock were issued:

3,925,000 shares of common issued for services. The Company valued the shares at $407,275 based on the price of the common stock on the date the Company agreed to issue the shares.

Preferred Stock

The Company has 100,000,000 shares authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

Series C Preferred Stock

Under the terms of the Certificate of Designation of Series C Preferred Stock, 12,000,000 shares of the Company’s preferred shares are designated as Series C Preferred Stock. Each share of Series C Preferred Stock is convertible into one hundred shares Common Stock and each share of Series C Preferred Stock is entitled to one hundred votes. As of December 31, 2023, and September 30, 2023, there were 600,000 shares of Series C Preferred Stock issued and outstanding.

Series D Preferred Stock

On September 30, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series D Preferred Stock, 10,000,000 shares of the Company’s preferred shares are designated as Series D Preferred Stock. Each share of Series D Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to two times the sum of all the number of shares of other classes of Corporation capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Corporation. As of December 31, 2023, and September 30, 2023, there were 50,000 shares of Series D Preferred Stock issued and outstanding.

Table of Contents

Series E Preferred Stock

On June 2, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 13,650,000 (as amended on June 10, 2021) were designated as Series E Preferred Stock. Each share of Series E Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series E Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. As of December 31, 2023, and September 30, 2023, there were no shares of Series E Preferred stock issued and outstanding.

Series F Preferred Stock

On November 24, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 59,270,000 were designated as Series F Preferred Stock. Each share of Series F Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock at any time by the holder. For so long as any shares of the Series F Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. The Series F Preferred Stock automatically converts to common stock after the shares of common stock closing market price is at least $0.20 for twenty (20) consecutive trading days. As of December 31, 2023, and September 30, 2023, there were no shares of Series F Preferred Stock issued and outstanding.

Stock Options

On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted an option to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $639,543 and will amortize the value over the three-year term of the agreement. For the three months ended December 31, 2023, no options vested.

On March 3, 2023, pursuant to a one-year consulting agreement, the Company granted an option to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $449,651 and will amortize the value over the one-year term of the agreement. For the three months ended December 31, 2023, no options vested.

The following table summarizes activities related to stock options of the Company for the year ended September 30, 2023, and there was no activity for three months ended December 31, 2023.

	Number of Options		Weighted- Average Exercise Price per Share		Weighted- Average Remaining Life (Years)
Outstanding at October 1, 2022		-	$	-		-
Issued		20,000,000	$	0.02		2.37
Outstanding at September 30, 2023		20,000,000	$	0.02		1.75
Exercisable at September 30, 2023		5,000,000	$	0.02		-
Outstanding at December 31, 2023		20,000,000	$	0.02		1.50
Exercisable at December 31, 2023		5,000,000	$	0.02		-

As of December 31, 2023, and September 30, 2023, 15,000,000 options to purchase shares of common stock remain unvested and $684,777 of stock compensation expense remains unrecognized and is being expensed over a weighted average period of 2.37 years from the date of the grant.

Table of Contents

Warrants

On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted a warrant to purchase 250,000 shares of RM common stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,458 and will amortize the value over the three-year term of the agreement. For the three months ended December 31, 2023, the Company has included $52,038 in General and Administrative expenses- related party.

On February 8, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2024.

On February 10, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $79,914, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,811, based on the Black Scholes option pricing model. The Company applied $43,416 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company will charge the note discount to interest expense over the term of the note. For the three months ended December 31, 2023, the Company recorded interest expense of $7,662.

On March 1, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2024.

On March 3, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $89,916, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,822, based on the Black Scholes option pricing model. The Company applied $43,585 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company will charge the note discount to interest expense over the term of the note. For the three months ended December 31, 2023, the Company recorded interest expenses of $7,692.

On March 3, 2023, pursuant to a one-year consulting agreement with a Company shareholder, the Company issued to the shareholder a warrant to purchase 250,000 shares of RM Stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,556 and will amortize the value over the one-year term of the agreement. For the three months ended December 31, 2023, the Company has included $156,139 in general and administrative expenses.

The following table summarizes activities related to warrants of the Company for the year ended September 30, 2023, and the three months ended December 31, 2023.

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding at October 1, 2022		-0-	$	-0-		-0-
Issued		8,000,000		0.0225		1.86
Outstanding and exercisable at September 30, 2023		8,000,000	$	0.0225		1.25
Outstanding and exercisable at December 31, 2023		8,000,000	$	0.0225		1.00

Table of Contents

The following table summarizes activities related to warrants to purchase RM Stock from the Company for the year ended September 30, 2023, and the three months ended December 31, 2023.

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding at October 1, 2022		-0-	$	-0-		-0-
Issued		900,000		1.00		2.15
Outstanding and exercisable at September 30, 2023		900,000	$	1.00		1.53
Outstanding and exercisable December 31, 2023		900,000	$	1.00		1.28

NOTE 9 - COMMITMENTS AND CONTINGENCIES

On November 24, 2020, a plaintiff (the “Plaintiff”) filed a complaint in the State District Court for Clark County, Nevada, naming Cytta as a Defendant. The Plaintiff contended that the Company had breached a written contract, or, in the alternative was liable to the Plaintiff for unjust enrichment. Cytta contended that no contract formation had ever occurred and that it had not been unjustly enriched by the Plaintiff. On or about January 15, 2021, the Defendant filed an Answer and Counterclaim in the litigation and contended that in fact the Plaintiff owed money to Cytta. A bench trial was held in June of 2022. In May of 2023, the Court which had presided over the bench trial ruled against the Plaintiff and in favor of Cytta, rejecting all the Plaintiff’s claims against Cytta. The Court also awarded damages to Cytta, and against the Plaintiff, on one of Cytta’s counterclaims, and subsequently also ruled that Cytta is entitled to recover certain of its costs and fees from the Plaintiff. The Plaintiff’s lawyer subsequently withdrew from representing the Plaintiff. The Plaintiff thereafter filed a pro se appeal without a lawyer. That Pro Se appeal has now been dismissed.

On July 19, 2022, the Company entered an Investor Awareness Advisory Services Agreement with a third party. Pursuant to the agreement in exchange for $10,000 per month over the three-month term (the “Term”) of the agreement, the third party will provide investor awareness advisory services (the “Services”). In addition, at the end of the Term, based upon the Company’s satisfaction with the Services, the Company will issue 500,000 shares of common stock to the provider’s designee. The shares were issued in December 2022.

On August 4, 2022 (the “Effective Date”), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,300,000 shares of restricted common stock over the one-year term of the agreement, the third party will provide financial consulting services to the Company. The shares are to be issued on a pro-rata basis, whereby the initial 325,000 shares were issued on August 8, 2022, and 325,000 shares were issued during the three months ended December 31, 2023.The Company recorded stock-based compensation expense of $50,150 for the three months ended December 31, 2022.

On November 16, 2022 (the “Effective Date”), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,000,000 shares of restricted common stock over the one-year term of the agreement the third party will provide financial consulting services to the Company. On December 5, 2022, the Company issued 500,000 shares and 250,000 shares were issued at the beginning of months seven and eight of the agreement.

On December 2, 2022 (the “Effective Date”), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,000,000 shares of restricted common stock. The shares were issued December 5, 2022.

On December 5, 2022, the Company issued 1,200,000 shares of common stock for services rendered pursuant to a consulting agreement. The Company also agreed to pay a monthly fee of $5,000 per month.

Table of Contents

On March 3, 2023, the Company entered a Consulting Agreement with an investor. Pursuant to the agreement, the Company issued 2,000,000 shares of common stock for one year of services. The Company valued the shares at $80,000 based on the price of the common stock on the date the Company agreed to issue the common stock. The Company also issued the consultant 1) an option to purchase 10,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share with an expiry date of July 1, 2025. The options vest over the two-year period in 25% increments beginning on the six- month anniversary of the agreement and 2) an option to purchase 250,000 shares of RM Stock at an exercise price of $1.00 per share with an expiry date of July 1, 2025. The warrant to purchase the Company’s common stock was valued at $449,651 based on the Black Scholes option pricing model and will be amortized over the one-year term of the agreement. For the three months ended December 31, 2023, $112,413 is included in stock-based compensation expense. The warrant to purchase the RM Stock was valued at $624,556 based on the Black Scholes option pricing model and will be amortized over the one-year term of the agreement. For the three months ended December 31, 2023, $156,139 is included in stock-based compensation expense. On May 11, 2023, the Company issued an additional 5,000,000 shares to the Consultant. On December 6, 2023, the Company agreed to issue an additional 6,000,000 shares of common stock. The Company valued the 6,000,000 shares at $0.0282 per share and included stock-based compensation expense of $169,200 for the three months ended December 31, 2023.

On April 1, 2023, the Company entered a Consulting Agreement with a third party for marketing services in exchange for 250,000 shares of restricted common stock. The shares vest in 12 equal amounts of 20,833. For the three months ended December 31, 2023, the Company has recorded stock-based compensation of $3,006 with the offset to accounts payable and accrued expenses.

On October 1, 2023, the Company entered into a one-year Agreement for Board of Advisor Services with a third party to provide general technical. AI, sales, and marketing services in exchange for 3,000,000 shares of common stock. The Company valued the shares at $80,700 ($0.0269 per share). The shares are to be issued at the end of the term, and the Company is amortizing the expense over the term of the contract. For the three months ended December 31, 2023, the Company included $20,175 in General and Administrative expenses and in accounts payable and accrued expenses.

NOTE 10 - LICENSE AGREEMENT

On August 9, 2022, the Company signed an Intellectual Property License Agreement (the “IPLA”) with Reticulate Micro, Inc. (“RM”). Pursuant to the ten-year term (the “Term”) of IPLA, RM agreed to issue to the Company 5,100,000 shares of RM’s Class A Common Stock and a royalty of 5% of net sales during the Term in exchange for the licensing of the Company’s technology related to its’ SUPR ISR (the Superior Utilization of Processing Resources- Intelligence, Surveillance and Reconnaissance).

RM, a Nevada corporation, was formed on June 22, 2022. Mr. Collins, the Company’s’ former CTO was a co-founder, and a former Director and President and Treasurer of RM. Mr. Chermak, the Company’s former COO is a co-founder, Director and Vice-president and Secretary of RM. Mr. Ansari is a co-founder and former Director of RM. RM had initially issued 1,600,000, 1,000,000 and 1,000,000 shares of Class B Common Stock to Mr. Collins. Mr. Chermak and Mr. Ansari, respectively. On May 15, 2023, Mr. Collins cancelled his 1,600,000 shares of Class B common stock in exchange for 200,000 shares of Class A common stock. As of December 31, 2023, and September 30, 2023, RM has 2,000,000 Class B Common Stock shares outstanding, respectively. Each share of the Class B Common Stock has voting rights whereby each share of Class B Common Stock equals 100 voting shares. As of December 31, 2023, and September 30, 2023, RM had 9,159,714 and 8,257,714 Class A common stock shares issued and outstanding, respectively. Accordingly, as of December 31, 2023, and September 30, 2023, the Company’s 5,100,000 shares of Class A Common Stock represent approximately 2.44% and 2.49%, respectively of the voting stock of RM. Each share of the Class B Common stock is also convertible into one share of Class A Common Stock.

The Company accounts for its interest in RM under the cost method of accounting. Due to RM just being formed at the time of the license agreement no value has been assigned to the investment.

Table of Contents

NOTE 11 - INCOME TAXES

The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely- than not that some or all of the deferred tax assets will not be realized.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of December 31, 2023, and 2022.

A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows:

	December 31, 2023			December 31, 2022
Pre-tax loss	$	(1,059,128	)	$	(1,100,708	)
U.S. federal corporate income tax rate		21	%		21	%
Expected U.S. income tax credit		(222,417	)		(231,149	)
Permanent differences		125,898			85,528
Change of valuation allowance		96,519			145,621
Effective tax expense	$	—		$	—

The Company had deferred tax assets as follows:

	December 31, 2023			December 31, 2022
Net operating losses carried forward	$	2,069,744		$	1,638,878
Less: Valuation allowance		(2,069,744	)		(1,638,878	)
Net deferred tax assets	$	—		$	—

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets meet the more-likely-than-not threshold for realizability. Accordingly, a full valuation allowance has been recorded against the Company’s deferred tax assets as of December 31, 2023, and September 30, 2023.

As of December 31, 2023, and September 30, 2023, the Company has approximately $9,855,000 and $9,396,000, respectively, net operating loss carryforwards available to reduce future taxable income. As of December 31, 2023, and September 30, 2023, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three months ended December 31, 2023, and 2022, and no provision for interest and penalties is deemed necessary as of December 31, 2023, and September 30, 2023.

NOTE 12 - DEFERRED REVENUE

The Company records the agreed amounts over the one-year term of the subscription agreements as deferred revenue, classified as a liability on the balance sheet, and amortizes the deferred revenue over the subscription period. For the three months ended December 31, 2023, and 2022, the Company recognized $2,411 and $5,706, respectively, of revenue from these agreements. As of December 31, 2023, all deferred revenue has been recognized.

Table of Contents

NOTE 13 - SUBSEQUENT EVENTS

On January 2, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for a monthly fee of $10,000 per month and 5,000,000 shares of common stock. The shares were issued on January 18, 2024.

On January 12, 2024, (the “Issuance Date”) the Company issued a convertible promissory note, in the principal amount of $250,000, to an investor. The note bears an interest rate of 18% per annum and matures on January 12, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to RM Stock owned by the Company. This note is convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. The Company received proceeds of $42,500 on January 10, 2024, $200,000 on January 12, 2024, and $7,500 on January 23, 2024.

On January 18, 2024, the Company issued 2,227,661 shares of common stock in satisfaction of $54,584 of accrued interest.

On January 29, 2024, the Company entered into a one-year Corporate Advisory Consulting Agreement with a third party to provide media, public relations, and investor relation services, in exchange for 3,000,000 shares of common stock.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying condensed consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward-looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

THE COMPANY

Results of Operations for the three months ended December 31, 2023, and 2022:

Revenues of $2,411 and $5,706 for the three months ended December 31, 2023, and 2022, respectively, were from deferred revenue on subscription agreements being recognized.

Revenues consist of our proprietary software, integration consulting services, tech support and product maintenance billed to the customer. Revenues decreased for the three months ended December 31, 2023, compared to the three months ended December 31, 2022, due to the lower deferred revenue recognized on subscription agreements entered into and being recognized in the current quarter.

Table of Contents

Operating expenses decreased by $115,991 for the three months ended December 31, 2023, compared to the three months ended December 31, 2022, as shown in the table below:

	December 31,
Description	2023		2022
Stock based expenses	$	599,516	$	551,668
Professional fees		45,001		53,146
Consulting expenses (excluding stock expenses)		167,000		199,787
Related party expenses (excluding stock expenses)		90,000		177,868
Depreciation expense		10,575		11,904
Equipment and demo expenses		286		25,369
General and Administrative officers		2,618		1,606
Auto, Travel and Meals and Entertainment		7,246		25,530
Rent expense		6,810		6,116
Investor relations expense		31,921		31,162
Other operating expenses		29,479		22,287
Total Operating expenses	$	990,452	$	1,106,443

Stock-based expenses increased in the current period compared to the prior period. For the three months ended December 31, 2023, stock-based expenses includes shares issued to consultants of $169,200, as well as the amortization of options, warrants and shares all previously issued of $430,316 for the three months ended December 31, 2023. For the three months ended December 31, 2022, stock-based expense includes $407,275 for the issuance of 3,925,000 shares to consultants. The expense is based on the price of the common stock on the dates the Company agreed to issue the shares. The Company also recorded $144,393 of expense related to commitments the Company incurred during the three months ended December 31, 2022.

Professional fees decreased in the current period compared to the prior period, substantially due to lower legal fees in the current period, due to less costs associated with the Skoblow case in the current period.

Consulting expenses decreased during the three months ended December 31, 2023, compared to the three months ended December 31, 2022, substantially as a result of fewer consultants.

Related party expenses decreased for the three months ended December 31, 2023, compared to the three months ended December 31, 2022, as follows:

	Three months ended December 31,
	2023		2022
Management fees, Chief Executive Officer (CEO)	$	45,000	$	60,000
Management fee; President and Chief Operating Officer (COO)		45,000		-
Chief Technology Officer (CTO), through March 31, 2023		-		60,000
Chief Administration Officer (CAO), through January 31, 2023		-		45,000
Office rent and expenses		-		12,868
Total	$	90,000	$	177,868

Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity to provide the services of a Chief Operating Officer (COO) of the Company. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000. The monthly fee was increased to $15,000 per month effective September 1, 2023.

On October 25, 2020, the Company entered into a sublease with its CTO, whereby the Company agreed to an annual lease payment of $50,000. On October 26, 2021, renewed he lease for an additional year for $3,500 per month, and on October 26, 2022, the lease was renewed on a month-to-month basis. Included in office rent and expenses for the three months ended December 31, 2022, is $10,500.

For the three months ended December 31, 2023, equipment and demo expenses decreased. For the three months ended December 31, 2022, the Company sent existing inventory out for demo purposes.

Table of Contents

Other expense, net, for the three months ended December 31, 2023, was $71,087, compared to other income, net of $29, for the three months ended December 31, 2022.

	Three months ended December 31,
	2023			2022
Interest expense	$	71,287		$	26
Interest income		(200	)		(55	)
Total other expense	$	71,087		$	(29	)

The increase in interest expense for the three months ended December 31, 2023, is primarily a result of the interest on convertible notes, as well as the amortization of note discounts.

The following tables set forth key components of our balance sheet as of December 31, 2023, and September 30, 2023.

	December 31, 2023			September 30, 2023

Current Assets	$	1,030,026		$	1,661,800

Long term assets	$	523,425		$	639,334

Total Assets	$	1,553,451		$	2,301,134

Current Liabilities	$	2,652,957		$	2,561,493

Total Liabilities	$	2,652,957		$	2,561,307

Stockholders’ Deficit	$	(1,099,506	)	$	(260,359	)

Total Liabilities and Stockholders’ Deficit	$	1,553,451		$	2,301,134

Liquidity and Capital Resources

As of December 31, 2023, we had limited operating capital. Our current capital and our other existing resources will not be sufficient to provide the working capital needed for our current business. Additional capital will be required to meet our obligations, and to further expand our business. We may be unable to obtain the additional capital required. Our inability to generate capital or raise additional funds when required will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations and the need to raise additional capital to fund operations. This “going concern” could impair our ability to finance our operations through the sale of debt or equity securities.

As of December 31, 2023, we had cash of $390,262 compared to $674,824 at September 30, 2023. As of December 31, 2023, we had current assets of $1,030,026 and current liabilities of $2,652,957, which resulted in working capital deficiency of $1,622,931. The current liabilities are comprised of accounts payable and accrued expenses, related party payables, convertible note payable, notes payable, and dividends payable.

Operating Activities

For the three months ended December 31, 2023, net cash used in operating activities was $324,562 compared to $611,781 for the three months ended December 31, 2022. For the three months ended December 31, 2023, our net cash used in operating activities was primarily attributable to the net loss of $1,059,128, adjusted by stock-based compensation of $599,516, amortization and depreciation of $25,929 and loss on extinguishment of debt of $3,955. Net changes of $105,166 in operating assets and liabilities decreased the cash used in operating activities.

Table of Contents

For the three months ended December 31, 2022, our net cash used in operating activities was primarily attributable to the net loss of $1,100,708, adjusted by stock-based compensation of $407,275 and depreciation of $11,904. Net changes of $69,748 in operating assets and liabilities decreased the cash used in operating activities.

Investing Activities

For the three months ended December 31, 2023, and 2022, there was no cash provided by investing activities.

Financing Activities

For the three months ended December 31, 2023, the Company received $40,000 in exchange for the issuance of a convertible promissory note. For the three months ended December 31, 2022, there were no financing activities.

Critical Accounting Policies

Our significant accounting policies are summarized in Note 3 of our financial statements. While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require management to use a greater degree of judgment and estimates. Actual results may differ from those estimates. Our management believes that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause an effect on our results of operations, financial position or liquidity for the periods presented in this report.

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Fair value of financial instruments

Table of Contents

The following are the hierarchical levels of inputs to measure fair value:

	●	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	●	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

Revenue Recognition

Stock-Based Compensation

The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (“SFAS No. 123R”)(ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in SFAS No. 123(R) (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.

Earnings (Loss) Per Share

The Company computes net loss per share in accordance with FASB ASC 260, “Earnings per Share.” ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the statement of operations. Basic EPS is computed by dividing net income (loss) available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period including stock options, using the treasury stock method, and convertible notes and stock warrants, using the if-converted method. In computing diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options, warrants and conversion of convertible notes. Diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive.

Table of Contents

Off Balance Sheet Arrangements

We have no off-balance sheet arrangements, including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not Applicable.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of December 31, 2023. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of December 31, 2023, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

	1.	We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

	2.	We did not maintain appropriate cash controls – As of December 31, 2023, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company’s bank accounts.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

Changes in Internal Controls over Financial Reporting

There has been no change in our internal control over financial reporting occurred during the three months ended December 31, 2023, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

None.

Item 1A. RISK FACTORS

Not applicable for smaller reporting companies.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following represents all shares issued during the quarter ended December 31, 2023:

On November 30, 2023, the Company issued 6,600 shares of restricted common stock in settlement of $165 of accrued interest.

On November 30, 2023, the Company issued 30,000 shares of restricted common stock in settlement of $750 of accrued interest.

On November 30, 2023, the Company issued 51,000 shares of restricted common stock in settlement of $1,275 of accrued interest.

On November 30, 2023, the Company issued 1,685,900 shares of restricted common stock in settlement of $42,148 of accrued interest.

On November 30, 2023, the Company issued 18,500 shares of restricted common stock in settlement of $550 of accrued interest.

On November 30, 2023, the Company issued 22,000 shares of restricted common stock in settlement of $462 of accrued interest.

On November 30, 2023, the Company issued 73,750 shares of restricted common stock in settlement of $1,475 of accrued interest.

On December 14, 2023, the Company issued 6,000,000 shares of restricted common stock to an existing Company shareholder, in exchange for consulting services provided to the Company. The shares were valued at $0.0282 per share, the market price, on the date the Company agreed to issue the shares.

The Company issued the foregoing securities in reliance on an exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506(b) promulgated thereunder, as there was no general solicitation to the investors and the transactions did not involve a public offering.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURE

Not applicable.

Item 5. OTHER INFORMATION

	(a)	None.
	(b)	During the quarter ended December 31, 2023, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors.

Table of Contents

Item 6. EXHIBITS

The following documents are filed as part of this report:

Exhibit No.		Description
3.1		Articles of Incorporation of Cytta Corp.*
3.2		Bylaws of the Company *
3.3		Amendment to Articles of Incorporation Amending Authorized Common and Preferred Stock *
3.4		Amended and Restated Certificate of Designation of Series D Preferred Stock *
3.5		Amended and Restated Certificate of Designation of Series E Preferred Stock *
3.6		Certificate of Designation of Series F Preferred Stock**
10.1		Agreement by and between Cytta Corp and Makena Investment Advisors, LLC dated April 1, 2020 *
10.2		Sublease Agreement by and between Cytta Corp and Michael Collins dated October 25, 2020 *
10.3		Agreement by and between Cytta Corp and Peter Rettman dated August 27, 2020 *
10.4		Share Issuance agreement by and between Cytta Corp and United Financial Inc., dated September 30, 2020 *
10.5		Technology Access Agreement by and between Cytta Corp and Michael Collins dated July 19, 2018 *
14.1		Code of Ethics *
31.1		Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002***
31.2		Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002***
32.1		Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63***
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).***
101.SCH		Inline XBRL Taxonomy Extension Schema Document.***
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.***
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.***
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document.***
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.***
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

* Incorporated by reference to the same exhibit to the registration statement filed by the Company on June 28, 2021.

** Incorporated by reference to exhibit 4.1 to the Current Report on Form 8-K filed by the Company on November 26, 2021.

*** Filed herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: February 16, 2024

*/s/ Gary Campbell*
Gary Campbell
Chief Executive Officer
(principal executive officer)
(principal financial and accounting officer)

nullnullnull

Cover - shares	3 Months Ended
Cover - shares	Dec. 31, 2023	Feb. 14, 2024
Cover [Abstract]
Entity Registrant Name	CYTTA CORP.
Entity Central Index Key	0001383088
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	No
Document Period End Date	Dec. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		441,946,581
Entity File Number	333-257458
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	98-0505761
Entity Address Address Line 1	5450 W Sahara Ave Suite 300A
Entity Address City Or Town	Las Vegas
Entity Address State Or Province	NV
Entity Address Postal Zip Code	89146
City Area Code	702
Local Phone Number	900-7022
Security 12g Title	Common Stock, $0.001 par value
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes

BALANCE SHEETS - USD ($)	Dec. 31, 2023	Sep. 30, 2023
Current Assets
Cash	$ 390,262	$ 674,824
Prepaid expenses	639,764	986,976
Total Current Assets	1,030,026	1,661,800
Prepaid expenses, non-current	456,443	561,776
Property and equipment, net	66,982	77,558
TOTAL ASSETS	1,553,451	2,301,134
Current Liabilities
Accounts payable and accrued expenses	553,942	546,335
Related party liabilities	803,447	772,532
Dividend payable	33,427	33,427
Deferred revenue	0	2,411
Note payable	40,000	40,000
Convertible notes payable, net of discount	1,222,141	1,166,788
Total Current Liabilities	2,652,957	2,561,493
COMMITMENTS AND CONTINGENCIES	0	0
Preferred stock par value $0.001; (100,000,000 shares authorized)
Common stock par value $.001; (500,000,000 shares authorized and 434,718,920 (December 31, 2023) and 426,831,170 (September 30 ,2023) shares issued and outstanding)	434,720	426,832
Additional paid in capital	32,127,732	31,915,639
Accumulated Deficit	(33,662,608)	(32,603,480)
Total Stockholders' Equity (Deficit)	(1,099,506)	(260,359)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	1,553,451	2,301,134
Series C Preferred Stock [Member]
Preferred stock par value $0.001; (100,000,000 shares authorized)
Preferred Stock value	600	600
Series D Preferred Stock [Member]
Preferred stock par value $0.001; (100,000,000 shares authorized)
Preferred Stock value	50	50
Series E Preferred Stock [Member]
Preferred stock par value $0.001; (100,000,000 shares authorized)
Preferred Stock value	0	0
Series F Preferred Stock [Member]
Preferred stock par value $0.001; (100,000,000 shares authorized)
Preferred Stock value	$ 0	$ 0

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2023	Sep. 30, 2023
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	100,000,000	100,000,000
Common stock share, par value	$ 0.001	$ 0.001
Common stock share, authorized	500,000,000	500,000,000
Common stock share, issued	434,718,920	426,831,170
Common stock share, outstanding	434,718,920	426,831,170
Series C Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	12,000,000	12,000,000
Preferred stock share, issued	600,000	600,000
Preferred stock share, outstanding	600,000	600,000
Series D Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	10,000,000	10,000,000
Preferred stock share, issued	50,000	50,000
Preferred stock share, outstanding	50,000	50,000
Series E Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	13,650,000	13,650,000
Preferred stock share, issued	0	0
Preferred stock share, outstanding	0	0
Series F Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	10,000,000	10,000,000
Preferred stock share, issued	0	0
Preferred stock share, outstanding	0	0

STATEMENT OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
STATEMENT OF OPERATIONS (Unaudited) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
STATEMENT OF OPERATIONS (Unaudited)
Revenues	$ 2,411	$ 5,706
Operating Expenses:
General and administration- related party expenses	213,208	177,868
General and administrative- other	777,244	928,575
Total operating expenses	990,452	1,106,443
Loss from Operations	(988,041)	(1,100,737)
Other expenses (income)
Interest expense	71,287	26
Interest income	(200)	(55)
Total Other Expenses (Income)	71,087	(29)
Loss before income taxes	(1,059,128)	(1,100,708)
Provision for income taxes	0	0
Net loss	$ (1,059,128)	$ (1,100,708)
Loss per share, basic and diluted	$ (0.00)	$ (0.00)
Weighted average shares outstanding Basic and diluted	428,575,956	380,882,100

Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Series C Preferred Stock Member	Series D Preferred Stock Member	Series E Preferred Stock Member	Series F Preferred Stock Member	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Sep. 30, 2022		600,000	50,000			379,760,670
Balance, amount at Sep. 30, 2022	$ 461,792	$ 600	$ 50	$ 0	$ 0	$ 379,761	$ 27,956,388	$ (27,875,007)
Common stock issued for services, shares						3,925,000
Common stock issued for services, amount	407,275	0	0	0	0	$ 3,925	403,350	0
Net loss	(1,100,708)	$ 0	$ 0	$ 0	$ 0	$ 0	0	(1,100,708)
Balance, shares at Dec. 31, 2022		600,000	50,000	0	0	383,685,670
Balance, amount at Dec. 31, 2022	(231,641)	$ 600	$ 50	$ 0	$ 0	$ 383,686	28,359,738	(28,975,715)
Balance, shares at Sep. 30, 2023		600,000	50,000			426,831,170
Balance, amount at Sep. 30, 2023	(260,359)	$ 600	$ 50	0	0	$ 426,832	31,915,639	(32,603,480)
Common stock issued for services, shares						6,000,000
Common stock issued for services, amount	169,200	0	0	0	0	$ 6,000	163,200	0
Net loss	(1,059,128)	0	0	0	0	$ 0	0	(1,059,128)
Common stock issued for accounts payable and accrued liabilities, shares						1,887,750
Common stock issued for accounts payable and accrued liabilities, amount	50,781	$ 0	$ 0	0	0	$ 1,888	48,893	0
Balance, shares at Dec. 31, 2023		600,000	50,000			434,718,920
Balance, amount at Dec. 31, 2023	$ (1,099,506)	$ 600	$ 50	$ 0	$ 0	$ 434,720	$ 32,127,732	$ (33,662,608)

Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
Statements of Cash Flows (Unaudited) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,059,128)	$ (1,100,708)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expenses for services	599,516	407,275
Amortization of note discounts	15,353	0
Loss on debt extinguishment	3,955	0
Depreciation expense	10,576	11,904
Changes in Operating Assets and Liabilities:
Accounts Receivable	0	(4,995)
Prepaid expenses	63,285	5,969
Accounts payable and accrued liabilities	31,252	101,376
Accounts payable-related party	13,040	(59,365)
Deferred revenue	(2,411)	26,763
Net cash used in operating activities	(324,562)	(611,781)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of short-term convertible notes payable	40,000	0
Net cash provided by financing activities	40,000	0
NET CHANGE IN CASH	(284,562)	(611,781)
CASH AT BEGINNING OF PERIOD	674,824	755,122
CASH AT END OF PERIOD	390,262	143,341
SUPPLEMENTAL CASH FLOW DISCLOSURES
Cash paid for interest	0	0
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for services	169,200	407,275
Common stock issued for accounts payable and accrued liabilities	$ 50,781	$ 0

ORGANIZATION AND DESCRIPTION OF BUSINESS

3 Months Ended

Dec. 31, 2023

ORGANIZATION AND DESCRIPTION OF BUSINESS

ORGANIZATION AND DESCRIPTION OF BUSINESS

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

GOING CONCERN

3 Months Ended

Dec. 31, 2023

GOING CONCERN

GOING CONCERN

NOTE 2 - GOING CONCERN

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

3 Months Ended

Dec. 31, 2023

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Prepaid expenses

	December 31,
	2023			2022
Balance beginning of period	$	1,548,752		$	32,897
Amortization of stock-based compensation		(389,260	)		-
Other prepaid expense activity		(63,285	)		(5,970	)
Sub-total		1,096,207			26,927
Less non-current portion		456,443			-
Prepaid expenses, current portion	$	639,764		$	26,927

Inventory

Property and equipment

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

	Vehicles and equipment	5 years
	Software	3 years

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Fair value of financial instruments

The following are the hierarchical levels of inputs to measure fair value:

	●	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	●	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

Revenue recognition

Stock-based compensation

Income taxes

Cash flows reporting

Reporting segments

Concentrations of Credit Risk

Earnings (Loss) Per Share of Common Stock

Recent Accounting Pronouncements

PROPERTY AND EQUIPMENT

3 Months Ended

Dec. 31, 2023

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

NOTE 4 - PROPERTY AND EQUIPMENT

The following table represents the Company’s property and equipment as of December 31, 2023, and September 30, 2023:

	December 31, 2023			September 30, 2023
Property and equipment	$	230,900		$	230,900
Accumulated depreciation		(163,918	)		(153,342	)
Property and equipment, net	$	66,982		$	77,558

Depreciation expense was $10,576 and $11,904 for the three months ended December 31, 2023, and 2022, respectively.

RELATED PARTY TRANSACTIONS

3 Months Ended

Dec. 31, 2023

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

NOTE 5 - RELATED PARTY TRANSACTIONS

Related Party agreements and fees

For the three months ended December 31, 2023, and 2022, the Company recorded expenses to related parties in the following amounts:

	Three months ended December 31,
	2023		2022
Management fees, Chief Executive Officer (CEO)	$	45,000	$	60,000
Chief Technology Officer (CTO) through April 30, 2023		-		60,000
Chief Administration Officer (CAO) through January 31, 2023		-		45,000
President and Chief Operating Officer (COO)		45,000		-
Stock-based compensation expense, officers		123,208		-
Office rent and expenses		-		12,868
Total	$	213,208	$	177,868

Accounts payable, related parties

As of December 31, 2023, and September 30, 2023, the Company owes $803,447 and $772,532, respectively, to related parties as follows:

	December 31, 2023		September 30, 2023
Management fees, Chief Executive Officer (CEO)	$	123,040	$	110,000
Bonus, CEO		70,000		70,000
Stock to be issued President and COO		580,407		562,532
Fees, bonus, and accounts payable, former CTO		30,000		30,000
Total	$	803,447	$	772,532

NOTE PAYABLE

3 Months Ended

Dec. 31, 2023

NOTE PAYABLE

NOTES PAYABLE

NOTE 6 - NOTE PAYABLE

CONVERTIBLE NOTES PAYABLE

3 Months Ended

Dec. 31, 2023

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE

NOTE 7 - CONVERTIBLE NOTES PAYABLE

The Company has the following convertible notes payable outstanding as of December 31, 2023, and September 30, 2023:

SCHEDULE OF NOTES PAYABLE

	December 31, 2023		September 30, 2023
Convertible note payable, interest at 18%, matures February 17, 2024	$	25,000	$	25,000
Convertible note payable, interest at 18%, matures February 24, 2024		25,000		25,000
Convertible note payable interest at 18%, matures February 28, 2024		10,000		10,000
Convertible note payable interest at 18%, matures May 3, 2024		50,000		50,000
Convertible note payable interest at 18%, matures June 16, 2024		500,000		500,000
Convertible note payable $50,000 face value, interest at 18%, matures July 1, 2024, net of discount of $15,888 (December) and $23,549 (September)		34,112		26,451
Convertible note payable $50,000 face value, interest at 18%, matures July 1, 2024, net of discount of $16,971 (December) and $24,663 (September)		33,029		25,337
Convertible note payable interest at 18%, matures August 2, 2024		500,000		500,000
Convertible note payable interest at 18%, matures August 2, 2024		5,000		5,000
Convertible note payable interest at 18%, matures December 28, 2024		40,000		-
Convertible notes payable, net of discounts of $32,859 (December) and $48,212 (September)	$	1,222,141	$	1,166,788

CAPITAL STOCK

3 Months Ended

Dec. 31, 2023

CAPITAL STOCK

CAPITAL STOCK

NOTE 8 - CAPITAL STOCK

Common Stock

During the three months ended December 31, 2023, the following shares of common stock were issued:

	·	6,000,000 shares of common issued for services. The Company valued the shares at $169,200 based on the price of the common stock on the date the Company agreed to issue the shares.

	·	1,887,750 shares issued for payment of $46,826 of accounts payable and accrued interest. The value of the shares issued was $50,781 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $3,955 in loss on debt extinguishment for the three months ended December 31, 2023.

During the three months ended December 31, 2022, the following shares of common stock were issued:

3,925,000 shares of common issued for services. The Company valued the shares at $407,275 based on the price of the common stock on the date the Company agreed to issue the shares.

Preferred Stock

Series C Preferred Stock

Series D Preferred Stock

Series E Preferred Stock

Series F Preferred Stock

Stock Options

The following table summarizes activities related to stock options of the Company for the year ended September 30, 2023, and there was no activity for three months ended December 31, 2023.

	Number of Options		Weighted- Average Exercise Price per Share		Weighted- Average Remaining Life (Years)
Outstanding at October 1, 2022		-	$	-		-
Issued		20,000,000	$	0.02		2.37
Outstanding at September 30, 2023		20,000,000	$	0.02		1.75
Exercisable at September 30, 2023		5,000,000	$	0.02		-
Outstanding at December 31, 2023		20,000,000	$	0.02		1.50
Exercisable at December 31, 2023		5,000,000	$	0.02		-

Warrants

The following table summarizes activities related to warrants of the Company for the year ended September 30, 2023, and the three months ended December 31, 2023.

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding at October 1, 2022		-0-	$	-0-		-0-
Issued		8,000,000		0.0225		1.86
Outstanding and exercisable at September 30, 2023		8,000,000	$	0.0225		1.25
Outstanding and exercisable at December 31, 2023		8,000,000	$	0.0225		1.00

The following table summarizes activities related to warrants to purchase RM Stock from the Company for the year ended September 30, 2023, and the three months ended December 31, 2023.

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding at October 1, 2022		-0-	$	-0-		-0-
Issued		900,000		1.00		2.15
Outstanding and exercisable at September 30, 2023		900,000	$	1.00		1.53
Outstanding and exercisable December 31, 2023		900,000	$	1.00		1.28

COMMITMENTS AND CONTINGENCIES

3 Months Ended

Dec. 31, 2023

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES

NOTE 9 - COMMITMENTS AND CONTINGENCIES

On December 5, 2022, the Company issued 1,200,000 shares of common stock for services rendered pursuant to a consulting agreement. The Company also agreed to pay a monthly fee of $5,000 per month.

LICENSE AGREEMENT

3 Months Ended

Dec. 31, 2023

LICENSE AGREEMENT

LICENSE AGREEMENT

NOTE 10 - LICENSE AGREEMENT

The Company accounts for its interest in RM under the cost method of accounting. Due to RM just being formed at the time of the license agreement no value has been assigned to the investment.

INCOME TAXES

3 Months Ended

Dec. 31, 2023

INCOME TAXES

INCOME TAXES

NOTE 11 - INCOME TAXES

A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows:

	December 31, 2023			December 31, 2022
Pre-tax loss	$	(1,059,128	)	$	(1,100,708	)
U.S. federal corporate income tax rate		21	%		21	%
Expected U.S. income tax credit		(222,417	)		(231,149	)
Permanent differences		125,898			85,528
Change of valuation allowance		96,519			145,621
Effective tax expense	$	—		$	—

The Company had deferred tax assets as follows:

	December 31, 2023			December 31, 2022
Net operating losses carried forward	$	2,069,744		$	1,638,878
Less: Valuation allowance		(2,069,744	)		(1,638,878	)
Net deferred tax assets	$	—		$	—

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets meet the more-likely-than-not threshold for realizability. Accordingly, a full valuation allowance has been recorded against the Company’s deferred tax assets as of December 31, 2023, and September 30, 2023.

DEFERRED REVENUE

3 Months Ended

Dec. 31, 2023

DEFERRED REVENUE

DEFERRED REVENUE

NOTE 12 - DEFERRED REVENUE

SUBSEQUENT EVENTS

3 Months Ended

Dec. 31, 2023

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS

NOTE 13 - SUBSEQUENT EVENTS

On January 18, 2024, the Company issued 2,227,661 shares of common stock in satisfaction of $54,584 of accrued interest.

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

3 Months Ended

Dec. 31, 2023

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

Use of Estimates

Cash and Cash Equivalents

Prepaid expenses

	December 31,
	2023			2022
Balance beginning of period	$	1,548,752		$	32,897
Amortization of stock-based compensation		(389,260	)		-
Other prepaid expense activity		(63,285	)		(5,970	)
Sub-total		1,096,207			26,927
Less non-current portion		456,443			-
Prepaid expenses, current portion	$	639,764		$	26,927

Inventory

Property and equipment

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

	Vehicles and equipment	5 years
	Software	3 years

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

Fair value of financial instruments

The following are the hierarchical levels of inputs to measure fair value:

	●	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	●	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	●	Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

Revenue recognition

Stock-based compensation

Income taxes

Cash flows reporting

Reporting segments

Concentrations of Credit Risk

Earnings (Loss) Per Share of Common Stock

Recent Accounting Pronouncements

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Dec. 31, 2023

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of amortization of the value of the stock issued

	December 31,
	2023			2022
Balance beginning of period	$	1,548,752		$	32,897
Amortization of stock-based compensation		(389,260	)		-
Other prepaid expense activity		(63,285	)		(5,970	)
Sub-total		1,096,207			26,927
Less non-current portion		456,443			-
Prepaid expenses, current portion	$	639,764		$	26,927

PROPERTY AND EQUIPMENT (Tables)

3 Months Ended

Dec. 31, 2023

PROPERTY AND EQUIPMENT

Schedule of property and equipment

	December 31, 2023			September 30, 2023
Property and equipment	$	230,900		$	230,900
Accumulated depreciation		(163,918	)		(153,342	)
Property and equipment, net	$	66,982		$	77,558

RELATED PARTY TRANSACTIONS (Tables)

3 Months Ended

Dec. 31, 2023

RELATED PARTY TRANSACTIONS

Schedule of recorded expenses to related parties

	Three months ended December 31,
	2023		2022
Management fees, Chief Executive Officer (CEO)	$	45,000	$	60,000
Chief Technology Officer (CTO) through April 30, 2023		-		60,000
Chief Administration Officer (CAO) through January 31, 2023		-		45,000
President and Chief Operating Officer (COO)		45,000		-
Stock-based compensation expense, officers		123,208		-
Office rent and expenses		-		12,868
Total	$	213,208	$	177,868

Schedule of Accounts payable related parties

	December 31, 2023		September 30, 2023
Management fees, Chief Executive Officer (CEO)	$	123,040	$	110,000
Bonus, CEO		70,000		70,000
Stock to be issued President and COO		580,407		562,532
Fees, bonus, and accounts payable, former CTO		30,000		30,000
Total	$	803,447	$	772,532

CONVERTIBLE NOTES PAYABLE (Tables)

3 Months Ended

Dec. 31, 2023

CONVERTIBLE NOTES PAYABLE

Schedule of notes payable

	December 31, 2023		September 30, 2023
Convertible note payable, interest at 18%, matures February 17, 2024	$	25,000	$	25,000
Convertible note payable, interest at 18%, matures February 24, 2024		25,000		25,000
Convertible note payable interest at 18%, matures February 28, 2024		10,000		10,000
Convertible note payable interest at 18%, matures May 3, 2024		50,000		50,000
Convertible note payable interest at 18%, matures June 16, 2024		500,000		500,000
Convertible note payable $50,000 face value, interest at 18%, matures July 1, 2024, net of discount of $15,888 (December) and $23,549 (September)		34,112		26,451
Convertible note payable $50,000 face value, interest at 18%, matures July 1, 2024, net of discount of $16,971 (December) and $24,663 (September)		33,029		25,337
Convertible note payable interest at 18%, matures August 2, 2024		500,000		500,000
Convertible note payable interest at 18%, matures August 2, 2024		5,000		5,000
Convertible note payable interest at 18%, matures December 28, 2024		40,000		-
Convertible notes payable, net of discounts of $32,859 (December) and $48,212 (September)	$	1,222,141	$	1,166,788

CAPITAL STOCK (Tables)

3 Months Ended

Dec. 31, 2023

CAPITAL STOCK

Schedule of activities related to stock options

	Number of Options		Weighted- Average Exercise Price per Share		Weighted- Average Remaining Life (Years)
Outstanding at October 1, 2022		-	$	-		-
Issued		20,000,000	$	0.02		2.37
Outstanding at September 30, 2023		20,000,000	$	0.02		1.75
Exercisable at September 30, 2023		5,000,000	$	0.02		-
Outstanding at December 31, 2023		20,000,000	$	0.02		1.50
Exercisable at December 31, 2023		5,000,000	$	0.02		-

Schedule of activities related to warrants

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding at October 1, 2022		-0-	$	-0-		-0-
Issued		8,000,000		0.0225		1.86
Outstanding and exercisable at September 30, 2023		8,000,000	$	0.0225		1.25
Outstanding and exercisable at December 31, 2023		8,000,000	$	0.0225		1.00

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding at October 1, 2022		-0-	$	-0-		-0-
Issued		900,000		1.00		2.15
Outstanding and exercisable at September 30, 2023		900,000	$	1.00		1.53
Outstanding and exercisable December 31, 2023		900,000	$	1.00		1.28

INCOME TAXES (Tables)

3 Months Ended

Dec. 31, 2023

INCOME TAXES

Schedule of reconciliation of the income tax rate

	December 31, 2023			December 31, 2022
Pre-tax loss	$	(1,059,128	)	$	(1,100,708	)
U.S. federal corporate income tax rate		21	%		21	%
Expected U.S. income tax credit		(222,417	)		(231,149	)
Permanent differences		125,898			85,528
Change of valuation allowance		96,519			145,621
Effective tax expense	$	—		$	—

Schedule of deferred tax assets

	December 31, 2023			December 31, 2022
Net operating losses carried forward	$	2,069,744		$	1,638,878
Less: Valuation allowance		(2,069,744	)		(1,638,878	)
Net deferred tax assets	$	—		$	—

GOING CONCERN (Details Narrative) - USD ($)	Dec. 31, 2023	Sep. 30, 2023
GOING CONCERN
Accumulated deficit	$ (33,662,608)	$ (32,603,480)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Prepaid expenses beginning balance	$ 1,548,752	$ 32,897
Amortization of stock-based compensation	(389,260)	0
Other prepaid expense activity	(63,285)	(5,970)
Prepaid expenses ending balance	1,096,207	26,927
Prepaid expenses non-current portion	456,443	0
Prepaid expenses current portion	$ 639,764	$ 26,927

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	3 Months Ended
	Dec. 31, 2023
Software Development [Member]
Property Plant And Equipment Usefu Life	3 years
Vehicles And Equipment [Member]
Property Plant And Equipment Usefu Life	5 years

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2023	Sep. 30, 2023
PROPERTY AND EQUIPMENT
Property and equipments	$ 230,900	$ 230,900
Accumulated depreciation	(163,918)	(153,342)
Property and equipment, Net	$ 66,982	$ 77,558

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	3 Months Ended
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
PROPERTY AND EQUIPMENT
Depreciation expenses	$ 10,576	$ 11,904

RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended
RELATED PARTY TRANSACTIONS (Details) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
Management fees, Chief Executive Officer (CEO) [Member]
Related party	$ 45,000	$ 60,000
Chief Technology Officer [Member]
Related party	0	60,000
Chief Administration Officer [Member]
Related party	0	45,000
Stock Based Compensation Expense Officers [Member]
Related party	123,208	0
Office Rent and Expenses [Member]
Related party	0	12,868
Total [Member]
Related party	213,208	177,868
President And Chief Operating Officer (COO) [Member]
Related party	$ 45,000	$ 0

RELATED PARTY TRANSACTIONS (Details 1) - USD ($)	Dec. 31, 2023	Sep. 30, 2023
Accounts payable related parties	$ 803,447	$ 772,532
Bonus And Accounts Payable CTO [Member]
Accounts payable related parties	30,000	30,000
Management fees, Chief Executive Officer (CEO) [Member]
Accounts payable related parties	123,040	110,000
Stock to be issued President and COO [Member]
Accounts payable related parties	580,407	562,532
Series F Preferred Stock [Member]
Accounts payable related parties	$ 70,000	$ 70,000

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)					1 Months Ended	3 Months Ended
	Mar. 03, 2023	Feb. 10, 2023	Jan. 02, 2023	Jan. 02, 2022	Oct. 26, 2021	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023	Oct. 25, 2020
Warrant exercise price		$ 1.00
Stock-based compensation	$ 169,200
General and Administrative expenses-related party						$ 777,244	$ 928,575
Annual lease payment									$ 50,000
Accounts payable related parties						803,447		$ 772,532
Warrant Member
Stock-based compensation						53,295
Consulting Executive Officer Agreement [Member]
Monthly fee						$ 10,000
Issuance of common stock shares per month						250,000
Purchase of common stock shares						10,000,000
Common stock price per share						$ 0.02
Expiry date						Jul. 01, 2025
Warrant to purchase of common stock						250,000
Warrant exercise price						$ 1.00
Black Scholes Option [Member]
Amortizatization expences						$ 639,543
Stock-based compensation						17,875
Black Scholes Option 1 [Member]
Amortizatization expences						624,458
General and Administrative expenses-related party						52,038
Chief Administrative Officer [Member]
Monthly fee						20,000
Accounts Payable CTO [Member]
Rent per month					$ 3,500	$ 10,500
Accounts Payable CTO [Member] \| Maximum [Member]
Monthly fee			$ 15,000	$ 18,000
Accounts Payable CEO [Member] \| Minimum [Member]
Monthly fee			$ 15,000	$ 15,000

NOTE PAYABLE (Details Narrative) - USD ($)	Jan. 10, 2023	Jan. 10, 2024
Percentage of face value	8.00%
Proceeds from debt or equity, amount	$ 1,000,000
Face value of promissory note	$ 40,000
Maturity date	Jan. 10, 2024
Subsequent Event [Member]
Debt principal balance		$ 43,200
Debt principal balance interest rate percentage		8.00%

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	3 Months Ended
CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	Dec. 31, 2023	Sep. 30, 2023
Convertible promissory note	$ 1,222,141	$ 1,166,788
February 17 2024 [Member]
Convertible promissory note	$ 25,000	25,000
Interest rate	18.00%
February 24 2024 [Member]
Convertible promissory note	$ 25,000	25,000
Interest rate	18.00%
February 28 2024 [Member]
Convertible promissory note	$ 10,000	10,000
Interest rate	18.00%
May 3 2024 [Member]
Convertible promissory note	$ 50,000	50,000
Interest rate	18.00%
June 16, 2024 [Member]
Convertible promissory note	$ 500,000	500,000
Interest rate	18.00%
July 1, 2024 [Member]
Convertible promissory note	$ 34,112	26,451
Interest rate	18.00%
July 1, 2024 One [Member]
Convertible promissory note	$ 33,029	25,337
Interest rate	18.00%
August 2, 2024 [Member]
Convertible promissory note	$ 500,000	500,000
Interest rate	18.00%
August 2, 2024 One [Member]
Convertible promissory note	$ 5,000	5,000
Interest rate	18.00%
December 28, 2024 [Member]
Convertible promissory note	$ 40,000	$ 0
Interest rate	18.00%

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)						1 Months Ended	3 Months Ended
CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)	Aug. 02, 2023	May 03, 2023	Mar. 03, 2023	Feb. 10, 2023	Jan. 10, 2023	Jun. 16, 2023	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023	Mar. 23, 2023
Convertible promissory note							$ 1,222,141		$ 1,166,788
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 0.025
Warrant to purchase				2,000,000
Warrant exercise price				$ 1.00
Interest expense							71,287	$ 26
Maturity date					Jan. 10, 2024
Stock price				$ 1.00
February 10 2023 [Member]
Convertible promissory note							50,000
Convertible notes payable, net of discount							$ 50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Warrant to purchase							100,000
Interest rate							18.00%
Expiry date							Jul. 01, 2025
Debt discount							$ 43,416
Interest expense							7,662
Convertible notes carrying value							34,112
Unamortized discounts							$ 15,888
Maturity date							Jul. 01, 2024
Stock price		$ 1.00	$ 1.00			$ 1.00
February 17 2023 [Member]
Convertible promissory note							$ 25,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Interest rate							18.00%
Maturity date							Feb. 17, 2024
Stock price							$ 1.00
Warrant exercise price							$ 1.00
February 24 2023 [Member]
Convertible promissory note							$ 25,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Interest rate							18.00%
Maturity date							Feb. 24, 2024
Stock price							$ 1.00
Warrant exercise price							$ 1.00
February 28 2023 [Member]
Convertible promissory note							$ 10,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Interest rate							18.00%
Maturity date							Feb. 28, 2024
Stock price							$ 1.00
Warrant exercise price							$ 1.00
March 3 2023 [Member]
Convertible promissory note							$ 50,000
Convertible notes payable, net of discount							$ 50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Warrant to purchase							100,000
Interest rate							18.00%
Expiry date							Jul. 01, 2025
Warrant exercise price							$ 1.00
Debt discount							$ 43,585
Interest expense							7,692
Convertible notes carrying value							33,029
Unamortized discounts							$ 16,971
Stock price							$ 1.00
May 3 2023 [Member]
Convertible promissory note		$ 50,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.02
Interest rate		18.00%
Stock price		$ 1.00
June 16 2023 [Member]
Convertible promissory note						$ 500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.025
Interest rate						18.00%
Stock price						$ 1.00
August 2, 2023 [Member]
Convertible promissory note	$ 500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.025
Interest rate	18.00%
Stock price	$ 1.00
August 2, 2023 One [Member]
Convertible promissory note	$ 5,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.025
Interest rate	18.00%
Stock price	$ 1.00
December 28, 2023 [Member]
Convertible promissory note							$ 40,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Interest rate							18.00%
Maturity date							Dec. 28, 2024
Stock price							$ 1.00

CAPITAL STOCK (Details) - Stock Options [Member] - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Number of options outstanding exercisable	5,000,000	5,000,000
Weighted Average Exercise Price, Exercisable	$ 0.02	$ 0.02
Weighted Average Exercise Price, Issued		0.02
Weighted Average Exercise Price, Beginning Balance	0.02
Weighted Average Exercise Price, ending Balance	$ 0.02	$ 0.02
Weighted Average Remaining Term in Years, Issued	2 years 4 months 13 days	2 years 4 months 13 days
Weighted Average Remaining Term in Years, Outstanding	1 year 6 months	1 year 9 months
Outstanding, Beginning Balance		20,000,000
Issued		20,000,000
Outstanding ending balance	20,000,000

CAPITAL STOCK (Details 1) - Warrants Member - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Number of share warrants issued		8,000,000
Weighted Average Remaining Term in Years, Issued		1 year 10 months 9 days
Weighted Average Exercise Price, Warrants issued		$ 0.0225
Weighted average exercise price per shares Exercisable	$ 0.0225	$ 0.0225
Weighted Average Remaining Term in Years, Outstanding and exercisable	1 year	1 year 3 months
Outstanding ending balance	8,000,000	8,000,000

CAPITAL STOCK (Details 2) - Warrants to purchase RM Stock Member - $ / shares	3 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2023
Number of share warrants issued		900,000
Weighted Average Exercise Price, Warrants issued		$ 1.00
Weighted Average Remaining Term in Years, Issued		2 years 1 month 24 days
Weighted Average Remaining Term in Years, Outstanding and exercisable	1 year 3 months 10 days	1 year 6 months 10 days
Outstanding ending balance	900,000	900,000
Weighted Average Exercise Price, ending Balance	$ 1.00	$ 1.00

CAPITAL STOCK (Details Narrative) - USD ($)			1 Months Ended			3 Months Ended		12 Months Ended
CAPITAL STOCK (Details Narrative) - USD ($)	Mar. 02, 2023	Feb. 08, 2023	Mar. 03, 2023	Feb. 02, 2023	Nov. 24, 2021	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2023	Dec. 06, 2023	May 11, 2023	Feb. 10, 2023	Feb. 01, 2023	Jun. 02, 2021	Sep. 30, 2020
Common stock shares, authorized						500,000,000		500,000,000
Common stock shares, par value						$ 0.001
Common stock shares, issued						434,718,920		426,831,170
Common stock share, outstanding						434,718,920		426,831,170
Common stock issued for services, shares						6,000,000	3,925,000
Common stock issued for services, amount						$ 169,200	$ 407,275
Common stock issued for payment of account payable share						1,887,750
Common stock issued for payment of account payable						$ 46,826
Common Stock issued Settlement Of Stock Payable						50,781
Loss on debt extinguishment						$ 3,955
Preferred stock, shares authorized						100,000,000		100,000,000
Preferred stock, par value						$ 0.001		$ 0.001
Interest expense						$ 71,287	$ 26
Consulting Agreement [Member]
Common stock shares, issued			2,000,000						6,000,000	5,000,000		250,000
Stock Options [Member]
Weighted Average Remaining Term in Years, Issued						2 years 4 months 13 days		2 years 4 months 13 days
Unrecognized stock compensation expense						$ 684,777
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, share						15,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award			10,000,000	10,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised			$ 0.02	$ 0.02
Vesting Percentage			25.00%	25.00%
Stock Option Value			$ 449,651	$ 639,543
Warrants Member
Weighted Average Remaining Term in Years, Issued								1 year 10 months 9 days
Warrants Member \| Consulting Agreement [Member]
General and Administrative expenses- related party						$ 156,139
Warant Exercise Price			$ 1.00
Fair value of warrant			$ 624,556
Warrant to purchase shares of RM Stock based on Black scholes option pricing Model, share			250,000
Warrant Member
General and Administrative expenses- related party						52,038
Warant Exercise Price	$ 0.02	$ 0.02	$ 0.025	$ 1.00							$ 0.025
Fair value of warrant			$ 89,916	$ 624,458							$ 79,914
Warrant to purchase shares of RM Stock, Shares	100,000	100,000	100,000								100,000
Warant Exercise Price RM Stock	$ 1.00	$ 1.00	$ 1.00								$ 1.00
Warrant To Purchase Share	2,000,000	2,000,000	2,000,000	250,000							2,000,000
Warrant to purchase shares of RM Stock based on Black scholes option pricing Model, value			$ 249,822								$ 249,811
Discount amount based on allocations			43,585								$ 43,416
Interest expense			$ 7,692			$ 7,662
Payment to acquire warrants	$ 5,000	$ 5,000
Series C Preferred Stock [Member]
Preferred stock, shares authorized						12,000,000		12,000,000
Preferred stock, par value						$ 0.001		$ 0.001
Designated preferred shares						12,000,000
Preferred stock shares issued						600,000		600,000
Preferred stock shares outstanding						600,000		600,000
Series D Preferred Stock [Member]
Preferred stock, shares authorized						10,000,000		10,000,000
Preferred stock, par value						$ 0.001		$ 0.001
Designated preferred shares														10,000,000
Preferred stock shares issued						50,000		50,000
Preferred stock shares outstanding						50,000		50,000
Series E Preferred Stock [Member]
Preferred stock, shares authorized						13,650,000		13,650,000
Preferred stock, par value						$ 0.001		$ 0.001
Designated preferred shares													13,650,000
Preferred stock shares issued						0		0
Preferred stock shares outstanding						0		0
Series F Preferred Stock [Member]
Number of shares issued during period, shares					59,270,000
Common stock price per shares					$ 0.20
Preferred stock, shares authorized						10,000,000		10,000,000
Preferred stock, par value						$ 0.001		$ 0.001
Preferred stock shares issued						0		0
Preferred stock shares outstanding						0		0

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)			1 Months Ended		3 Months Ended
	Mar. 03, 2023	Aug. 08, 2022	Jul. 22, 2022	Jul. 19, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 06, 2023	Sep. 30, 2023	May 11, 2023	Apr. 01, 2023	Feb. 10, 2023	Feb. 01, 2023	Dec. 05, 2022	Dec. 02, 2022	Nov. 16, 2022	Aug. 04, 2022
Common stock shares issued					434,718,920			426,831,170
General and administrative expenses					$ 213,208	$ 177,868
Stock based compensation expense	$ 169,200
Warrant to purchase											2,000,000
Purchase of warrant value	$ 449,651
December 2, 2022 [Member]
Issuance of restricted common stock shares														1,000,000
August 4, 2022 [Member]
Common stock to be issued		325,000			325,000
Stock based compensation expense						$ 50,150
Consulting Agreement [Member]
Common stock shares issued	2,000,000						6,000,000		5,000,000			250,000
Monthly fee												$ 10,000	$ 5,000
Issuance of restricted common stock shares												10,000,000	1,200,000		1,000,000	1,300,000
Initial shares issued	10,000,000											250,000	250,000
Common stock share, par value	$ 1.00											$ 0.02
Voting stock percentage	25.00%											25.00%
Stock-based compensation	$ 112,413
Stock based compensation expense	$ 156,139
Warrant to purchase	624,556
Consulting Agreement [Member] \| April 1, 2023 [Member]
Issuance of restricted common stock shares										250,000
Shares vest in equal amounts										20,833
Stock based compensation expense					$ 3,006
Investor Awareness Advisory Services Agreement [Member]
Common stock shares issued				500,000
Investor awareness advisory services, expense amount				$ 10,000
Common stock share, par value												$ 1.00
Platform Account Contract [Member]
Platform account contract, expense amount			$ 500,000
Marketing Services Agreement [Member] \| October 1, 2023 [Member]
Common stock share, par value					$ 0.0269							$ 0.02
General and administrative expenses					$ 20,175
Common stock to be issued					3,000,000
Common stock to be issued, value					$ 80,700

LICENSE AGREEMENT (Details Narrative) - shares	Aug. 09, 2022	Dec. 31, 2023	Sep. 30, 2023	May 15, 2023	Jun. 22, 2022
Common stock shares issued		434,718,920	426,831,170
Common Stock Class B [Member] \| Mr Collins [Member]
Common stock shares issued					1,600,000
Cancellation of common stock				1,600,000
Total number of share exchanged				200,000
Common Stock Class B [Member] \| Mr Chermak [Member]
Common stock shares issued					1,000,000
Common Stock Class B [Member] \| Mr Ansari [Member]
Common stock shares issued					1,000,000
Common Stock Class A [Member] \| Intellectual Property License Agreement [Member]
Common stock shares issued	5,100,000	9,159,714	8,257,714
Royalty percentage of net sale	5.00%
Common Stock Class B [Member]
Common Stock shares outstanding		2,000,000	2,000,000
Common Stock voting shares		100	100
Class A [Member]
Common stock shares issued		5,100,000	5,100,000
Voting stock percentage		2.44%	2.49%

INCOME TAXES (Details ) - U.S. statutory [Memner] - USD ($)	3 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Pre-tax loss	$ (1,059,128)	$ (1,100,708)
U.S. federal corporate income tax rate	21.00%	21.00%
Expected U.S. income tax credit	$ (222,417)	$ (231,149)
Permanent differences	125,898	85,528
Change of valuation allowance	96,519	145,621
Effective tax expense	$ 0	$ 0

INCOME TAXES (Details 1) - USD ($)	3 Months Ended
INCOME TAXES (Details 1) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
INCOME TAXES
Net operating losses carried forward	$ 2,069,744	$ 1,638,878
Less: Valuation allowance	(2,069,744)	(1,638,878)
Net deferred tax assets	$ 0	$ 0

INCOME TAXES (Details Narrative) - USD ($)	Dec. 31, 2023	Sep. 30, 2023
INCOME TAXES
Net operating loss carryforwards	$ 9,855,000	$ 9,396,000

DEFERRED REVENUE (Details Narrative) - USD ($)	3 Months Ended
DEFERRED REVENUE (Details Narrative) - USD ($)	Dec. 31, 2023	Dec. 31, 2022
DEFERRED REVENUE
Deferred revenues	$ 2,411	$ 5,706

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)			1 Months Ended
	Jan. 12, 2024	Jan. 10, 2024	Jan. 23, 2024	Jan. 29, 2024	Jan. 18, 2024
Common stock, shares issued	5,000,000			3,000,000
Common stock issued for settlement of accrued interest					2,227,661
Accrued interest					$ 54,584
Proceeds from convertible promissory note	$ 200,000	$ 42,500	$ 7,500
Monthly fee amount	10,000
Convertible promissory note, principal amount	$ 250,000
Interest rate	18.00%
Convertible promissory note, conversion price per share	$ 0.025
Stock price per share	1.00
Outstanding principal and interest, per share amount	$ 1.00